Understanding drug resistance in malaria parasites: Basic science for public health

Molecular and Biochemical Parasitology

Volumn 195, Issue 2, 2014, Pages 107-114

  Sibley, Carol Hopkins ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antimalarial resistance; Drug selection; Genetics; Plasmodium falciparum

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ; ARTESUNATE; BENFLUMETOL; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FOLIC ACID ANTAGONIST; LUME; MEFLOQUINE; MOLECULAR MARKER; PIPERAQUINE; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; PYRONARIDINE; SULFADOXINE; UNCLASSIFIED DRUG;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; DRUG TREATMENT FAILURE; NONHUMAN; PLASMODIUM; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; DRUG EFFECTS; DRUG RESISTANCE; HUMAN; MALARIA, FALCIPARUM; MEDICAL RESEARCH; PARASITOLOGY; PHYSIOLOGY;

PLASMODIUM FALCIPARUM;

ANTIMALARIALS; BIOMEDICAL RESEARCH; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PUBLIC HEALTH;

EID: 84906938537     PISSN: 01666851     EISSN: 18729428     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2014.06.001     Document Type: Review

References (97)

1. C.V. Plowe Monitoring antimalarial drug resistance: making the most of the tools at hand J Exp Biol 206 2003 3745 3752 (Pubitemid 37365456)
2. C. Faurant From bark to weed: the history of artemisinin Parasite 18 2011 215 218
3. J. Achan, A.O. Talisuna, A. Erhart, A. Yeka, J.K. Tibenderana, and F.N. Baliraine et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria Malar J 10 2011 144
4. J.L.A. Webb The long shadow of malaria interventions in tropical Africa Lancet 374 2009 1883 1884
5. G. Charmot, J. Amat-Roze, F. Rodhain, J. Le Bras, and J. Coulaud Geographic approach to the epidemiology of chloroquine-resistance of Plasmodium falciparum in tropical Africa Ann Soc Belg Med Trop 71 1991 187 197
6. WHO Guidelines for treatment of malaria second ed. 2010 World Health Organization http://www.who.int/malaria/publications/atoz/9789241547925/en/ index.html [accessed 21.05.14]
7. W. Trager, and J.B. Jensen Human malaria parasites in continous culture Science 193 1976 673 675
8. R.E. Desjardins, C.J. Canfield, J.H. Haynes, and J.D. Chulay Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique Antimicrob Agents Chemother 16 1979 710 718 (Pubitemid 10082023)
9. X. Su, M.T. Ferdig, Y. Huang, C.Q. Huynh, A. Liu, and J. You et al. A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum [see comments] Science 286 1999 1351 1353
10. D.A. Fidock, T. Nomura, A.K. Talley, R.A. Cooper, S.M. Dzekunov, and M.T. Ferdig et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance Mol Cell 6 2000 861 871
11. N.K. Baro, P.S. Callaghan, and P.D. Roepe Function of resistance conferring Plasmodium falciparum chloroquine resistance transporter isoforms Biochemistry 52 2013 4242 4249
12. A. Ecker, A.M. Lehane, J. Clain, and D.A. Fidock PfCRT and its role in antimalarial drug resistance Trends Parasitol 28 2012 504 514
13. R. Durand, S. Jafari, J. Vauzelle, J.F. Delabre, Z. Jesic, and J. Le Bras Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum Mol Biochem Parasitol 114 2001 95 102 (Pubitemid 32453219)
14. A. Djimde, O.K. Doumbo, J.F. Cortese, K. Kayentao, S. Doumbo, and Y. Diourte et al. A molecular marker for chloroquine-resistant falciparum malaria N Engl J Med 344 2001 257 263 (Pubitemid 32108530)
15. J.C. Wootton, X. Feng, M.T. Ferdig, R.A. Cooper, J. Mu, and D.I. Baruch et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum Nature 418 2002 320 323 (Pubitemid 34790681)
16. S.J. Foote, D.E. Kyle, R.K. Martin, A.M. Oduola, K. Forsyth, and D.J. Kemp et al. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum [see comments] Nature 345 1990 255 258
17. L.K. Basco, J. Le Bras, Z. Rhoades, and C.M. Wilson Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from Subsaharan Africa Molec Biochem Parasitol 74 1995 157 166 (Pubitemid 26024474)
18. M. Duraisingh, P. Jones, I. Sambou, L. von Seidlein, M. Pinder, and D. Warhurst The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin Mol Biochem Parasitol 108 2000 13 23 (Pubitemid 30236312)
19. E.O. Ochong, I.V. van den Broek, K. Keus, and A. Nzila Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan Am J Trop Med Hyg 69 2003 184 187
20. R.N. Price, C. Cassar, A. Brockman, M. Duraisingh, M. van Vugt, and N.J. White et al. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand Antimicrob Agents Chemother 43 1999 2943 2949
21. S.R. Meshnick, and M. Dobson History of antimalarial drugs P.J. Rosenthal, Antimalarial chemotherapy: mechanisms of action, resistance, and new directions in drug discovery 2001 Humana Press Totowa, NJ
22. G.H. Hitchings, E.A. Falco, H. Vanderwerff, P.B. Russell, and G.B. Elion Antagonists of nucleic acid derivatives. VII: 2,4-Diaminopyrimidines J Biol Chem 199 1952 43 56
23. E.A. Falco, L.G. Goodwin, G.H. Hitchings, I.M. Rollo, and P.B. Russell 2,4-Diaminopyrimidines - a new series of antimalarials Br J Pharmacol Chemother 6 1951 185 200
24. D.F. Clyde Observations on monthly pyrimethamine (daraprim) prophylaxis in an East African village East Afr Med J 31 1954 41 46
25. D.F. Clyde Plasmodium falciparum resistant to pyrimethamine in non-immune Europeans in Tanganyika East Afr Med J 35 1958 181 186
26. J. Greenberg, and E.M. Richeson Potentiation of the antimalarial activity of sulfadiazine by 2,4-diamino-5-aryloxypyrimidines J Pharmacol Exp Ther 99 1950 444 449
27. G.M. Brown The biosynthesis of folic acid. II: Inhibition of sulfonamides J Biol Chem 237 1962 536 540
28. W. Peters Chemotherapy and drug resistance in malaria 1987 Academic Press London
29. A.F. Cowman, M.J. Morry, B.A. Biggs, G.A. Cross, and S.J. Foote Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum Proc Natl Acad Sci U S A 85 1988 9109 9113 (Pubitemid 19001849)
30. D.S. Peterson, D. Walliker, and T.E. Wellems Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria Proc Natl Acad Sci U S A 85 1988 9114 9118 (Pubitemid 19001850)
31. P. Wang, C.S. Lee, R. Bayoumi, A. Djimde, O. Doumbo, and G. Swedberg et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins Mol Biochem Parasitol 89 1997 161 177 (Pubitemid 27435090)
32. T. Triglia, and A.F. Cowman The mechanism of resistance to sulfa drugs in Plasmodium falciparum Drug Resist Update 2 1999 15 19 (Pubitemid 29217090)
33. M.T. Duraisingh, J. Curtis, and D.C. Warhurst Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion Exp Parasitol 89 1998 1 8 (Pubitemid 28377366)
34. C. Wongsrichanalai, A.L. Pickard, W.H. Wernsdorfer, and S.R. Meshnick Epidemiology of drug-resistant malaria Lancet Infect Dis 2 2002 209 218 (Pubitemid 34464751)
35. C. Plowe Antimalarial drug resistance in Africa: strategies for monitoring and deterrence Curr Top Microbiol Immunol 295 2005 55 79 (Pubitemid 41236511)
36. S. Picot, P. Olliaro, F. de Monbrison, A. Bienvenu, R. Price, and P. Ringwald A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria Malar J 8 2009 89
37. C.H. Sibley, and R.N. Price Monitoring antimalarial drug resistance: applying lessons learned from the past in a fast-moving present Int J Parasitol: Drugs Drug Resist 2 2012 126 133
38. L.K. Basco, and J. Le Bras In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains Bull Soc Pathol Exot 90 1997 90 93
39. P. Wang, P.F. Sims, and J.E. Hyde A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance Parasitology 115 1997 223 230 (Pubitemid 27394548)
40. L.K. Basco, R. Tahar, and P. Ringwald Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites Antimicrob Agents Chemother 42 1998 1811 1814 (Pubitemid 28311584)
41. J.G. Kublin, F.K. Dzinjalamala, D.D. Kamwendo, E.M. Malkin, J.F. Cortese, and L.M. Martino et al. Molecular markers for failure of sulfadoxine- pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria J Infect Dis 185 2002 380 388 (Pubitemid 34107252)
42. C.V. Plowe, J.G. Kublin, and O.K. Doumbo P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates Drug Resist Update 1 1998 389 396
43. A. Djimde, O.K. Doumbo, R.W. Steketee, and C.V. Plowe Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria Lancet 358 2001 890 891 (Pubitemid 32900575)
44. R. Shretta, J. Omumbo, B. Rapuoda, and R.W. Snow Using evidence to change antimalarial drug policy in Kenya Trop Med Int Health 5 2000 755 764 (Pubitemid 32001034)
45. J.G. Kublin, J.F. Cortese, E.M. Njunju, R.A.M. Wirima, J.J. Kazembe, and P.N. Djimde et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi J Infect Dis 187 2003 1870 1875 (Pubitemid 36724485)
46. M. Laufer, and C. Plowe Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies Drug Resist Update 7 2004 279 288 (Pubitemid 39469100)
47. A.E. Frosch, M.K. Laufer, D.P. Mathanga, S. Takala-Harrison, J. Skarbinski, and C.W. Claassen et al. The return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi J Infect Dis 2014
48. S. Nkhoma, M. Molyneux, and S. Ward Molecular surveillance for drug-resistant Plasmodium falciparum malaria in Malawi Acta Trop 102 2007 138 142 (Pubitemid 46898951)
49. L. Kalilani-Phiri, D. Lungu, and R. Coghlan Knowledge and malaria treatment practices using artemisinin combination therapy (ACT) in Malawi: survey of health professionals Malar J 10 2011 279
50. WHO Global report on antimalarial drug efficacy and drug resistance: 2000-2010 2010 World Health Organization Geneva http://www.who.int/malaria/ publications/atoz/9789241500470/en/ [accessed 21.05.14]
51. J.F. Cortese, A. Caraballo, C.E. Contreras, and C.V. Plowe Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America J Infect Dis 186 2002 999 1000
52. F. Ariey, T. Fandeur, R. Durand, M. Randrianarivelojosia, R. Jambou, and E. Legrand et al. Invasion of Africa by a single pfcrt allele of South East Asian type Malar J 5 2006 34
53. C. Roper, R. Pearce, B. Bredenkamp, J. Gumede, C. Drakeley, and F. Mosha et al. Antifolate antimalarial resistance in southeast Africa: a population-based analysis Lancet 361 2003 1174 1181 (Pubitemid 36398386)
54. C. Roper, R. Pearce, S. Nair, B. Sharp, F. Nosten, and T. Anderson Intercontinental spread of pyrimethamine-resistant malaria Science 305 2004 1124 (Pubitemid 39100317)
55. N. Noranate, R. Durand, A. Tall, L. Marrama, A. Spiegel, and C. Sokhna et al. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use PLoS ONE 2 2007 e139
56. L.K. Certain, M. Briceno, S.M. Kiara, A.M. Nzila, W.M. Watkins, and C.H. Sibley Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987-2006 J Infect Dis 197 2008 1743 1751 (Pubitemid 351919640)
57. O. Maiga, A.A. Djimde, V. Hubert, E. Renard, A. Aubouy, and F. Kironde et al. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa J Infect Dis 196 2007 165 172 (Pubitemid 46982751)
58. A.L. Malisa, R.J. Pearce, S. Abdulla, H. Mshinda, P.S. Kachur, and P. Bloland et al. Drug coverage in treatment of malaria and the consequences for resistance evolution - evidence from the use of sulphadoxine/pyrimethamine Malar J 9 2010 190
59. R.J. Pearce, H. Pota, M.S. Evehe, H. Ba el, G. Mombo-Ngoma, and A.L. Malisa et al. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria PLoS Med 6 2009 e1000055
60. R.K. Mehlotra, G. Mattera, M.J. Bockarie, J.D. Maguire, J.K. Baird, and Y.D. Sharma et al. Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum Antimicrob Agents Chemother 52 2008 2212 2222 (Pubitemid 351758561)
61. J.F. Trape, G. Pison, M.P. Preziosi, C. Enel, A. Desgrees du Lou, and V. Delaunay et al. Impact of chloroquine resistance on malaria mortality C R Acad Sci III 321 1998 689 697 (Pubitemid 28438430)
62. J.F. Trape The public health impact of chloroquine resistance in Africa Am J Trop Med Hyg 64 2001 12 17
63. N.J. White, F. Nosten, S. Looareesuwan, W.M. Watkins, K. Marsh, and R.W. Snow et al. Averting a malaria disaster Lancet 353 1999 1965 1967 (Pubitemid 29255721)
64. R.W. Snow, J.F. Trape, and K. Marsh The past, present and future of childhood malaria mortality in Africa Trends Parasitol 17 2001 593 597 (Pubitemid 34088120)
65. T. Mita, K. Tanabe, and K. Kita Spread and evolution of Plasmodium falciparum drug resistance Parasitol Int 58 2009 201 209
66. N. White, and P. Olliaro Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria Parasitol Today 12 1996 399 401 (Pubitemid 26306804)
67. F. Nosten, M. van Vugt, R. Price, C. Luxemburger, K.L. Thway, and A. Brockman et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study Lancet 356 2000 297 302 (Pubitemid 30459588)
68. J. Burrows, R. Hooft van Huijsduijnen, J. Mohrle, C. Oeuvray, and T. Wells Designing the next generation of medicines for malaria control and eradication Malar J 12 2013 187
69. E.L. Flannery, A.K. Chatterjee, and E.A. Winzeler Antimalarial drug discovery [mdash] approaches and progress towards new medicines Nat Rev Microbiol 11 2013 849 862
70. WHO World malaria report Organization WH Geneva 2013 2013 http://apps.who.int/iris/handle/10665/43417 [accessed 21.05.14]
71. C. Wongsrichanalai, and C.H. Sibley Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance Clin Microbiol Infect 19 2013 908 916
72. N.J. White Delaying antimalarial drug resistance with combination chemotherapy Parassitology 41 1999 301 308
73. A.M. Dondorp, F. Nosten, P. Yi, D. Das, A.P. Phyo, and J. Tarning et al. Artemisinin resistance in Plasmodium falciparum malaria N Engl J Med 361 2009 455 467
74. J.A. Flegg, P.J. Guerin, N.J. White, and K. Stepniewska Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator Malar J 10 2011 339
75. T.J. Anderson, S. Nair, S. Nkhoma, J.T. Williams, M. Imwong, and P. Yi et al. High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia J Infect Dis 201 2010 1326 1330
76. A.P. Phyo, S. Nkhoma, K. Stepniewska, E.A. Ashley, S. Nair, and R. McGready et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study Lancet 379 2012 1960 1966
77. WHO Global plan for atemisinin resistance containment 2011 World Health Organization Geneva http://www.who.int/malaria/publications/atoz/9789241500838/ en/index.html [accessed 21.05.14]
78. WHO Emergency response to artemisinin resistance in the greater Mekong subregion 2013 World Health Organization Geneva http://www.who.int/malaria/ areas/greater-mekong/en/ [accessed 21.05.14]
79. M.J. Gardner, N. Hall, E. Fung, O. White, M. Berriman, and R.W. Hyman et al. Genome sequence of the human malaria parasite Plasmodium falciparum Nature 419 2002 498 511
80. M. Manske, O. Miotto, S. Campino, S. Auburn, J. Almagro-Garcia, and G. Maslen et al. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing Nature 487 2012 375 379
81. I.H. Cheeseman, B.A. Miller, S. Nair, S. Nkhoma, A. Tan, and J.C. Tan et al. A major genome region underlying artemisinin resistance in malaria Science 336 2012 79 82
82. S. Takala-Harrison, T.G. Clark, C.G. Jacob, M.P. Cummings, O. Miotto, and A.M. Dondorp et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia Proc Natl Acad Sci U S A 110 2013 240 245
83. B. Witkowski, J. Lelievre, M.J. Barragan, V. Laurent, X.Z. Su, and A. Berry et al. Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism Antimicrob Agents Chemother 54 2010 1872 1877
84. B. Witkowski, N. Khim, P. Chim, S. Kim, S. Ke, and N. Kloeung et al. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in Western Cambodia Antimicrob Agents Chemother 57 2013 914 923
85. T.S. Skinner, L.S. Manning, W.A. Johnston, and T.M.E. Davis In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs Int J Parasitol 26 1996 519 525 (Pubitemid 26244548)
86. F. ter Kuile, N.J. White, P. Holloway, G. Pasvol, and S. Krishna Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria Exp Parasitol 76 1993 85 95 (Pubitemid 23197907)
87. B. Witkowski, C. Amaratunga, N. Khim, S. Sreng, P. Chim, and S. Kim et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drug-response studies Lancet Infect Dis 13 2013 1043 1049
88. F. Ariey, B. Witkowski, C. Amaratunga, J. Beghain, A.-C. Langlois, and N. Khim et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria Nature 505 2014 50 55
89. J. Adams, R. Kelso, and L. Cooley The kelch repeat superfamily of proteins: propellers of cell function Trends Cell Biol 10 2000 17 24 (Pubitemid 30017862)
90. L.M. Boyden, M. Choi, K.A. Choate, C.J. Nelson-Williams, A. Farhi, and H.R. Toka et al. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities Nature 482 2012 98 102
91. O. Miotto, J. Almagro-Garcia, M. Manske, B. Macinnis, S. Campino, and K.A. Rockett et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia Nat Genet 45 2013 648 655
92. R.J. Maude, W. Pontavornpinyo, S. Saralamba, R. Aguas, S. Yeung, and A.M. Dondorp et al. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia Malar J 8 2009 31
93. WWARN 'Big data' - harnessing the power of pooled analyses to prolong the efficacy of treatment 2014 World Wide Antimalarial Resistance Network Oxford, UK
94. M. Venkatesan, N.B. Gadalla, K. Stepniewska, P. Dahal, C. Nsanzabana, and C. Moriera et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine Am J Trop Med Hyg 2014
95. A.K. Lukens, L.S. Ross, R. Heidebrecht, F. Javier Gamo, M.J. Lafuente-Monasterio, and M.L. Booker et al. Harnessing evolutionary fitness in Plasmodium falciparum for drug discovery and suppressing resistance Proc Natl Acad Sci U S A 111 2014 799 804
96. X. Ding, D. Ubben, and T. Wells A framework for assessing the risk of resistance for anti-malarials in development Malar J 11 2012 292
97. M.D. Conrad, N. LeClair, E. Arinaitwe, H. Wanzira, A. Kakuru, and V. Bigira et al. Comparative impacts over 5 years of artemisinin-based combination therapies on P. falciparum polymorphisms that modulate drug sensitivity in Ugandan children J Infect Dis 2014